Cancer Data and Statistics Tools

Cancer Statistics Tools

United States Cancer Statistics: Data Visualizations
The U. S. Cancer Statistics Data Visualizations tool provides information on the numbers and rates of new cancer cases and deaths at the national, state, and county levels. You can see the numbers by sex, age, race and ethnicity, trends over time, survival, and prevalence. Text explains what is shown on each chart and graph.

CDC WONDER
This online query system lets you see age-adjusted and crude cancer rates in tabs, maps, and charts. It includes data on adult and childhood cancers by geographic region.

State Cancer Profiles
You can use State Cancer Profiles to view rates of new cancers at a county level, including a description of trends to see if rates are stable, falling, or rising in your area.

Small Area Health Insurance Estimates (SAHIE)
SAHIE provides data publications, interactive visualizations, and maps to help identify areas with high rates of uninsured and under-insured people so programs can target those in greatest need.

Sortable Stats
Get national and state-level colorectal cancer screening rates by race, ethnicity, and sex.

Disability and Health Data System
Provides state-level health and demographic data about people with disabilities.

Databases Available to Researchers

United States Cancer Statistics: Public Use Database
As a researcher, you can analyze population-based incidence data on the entire United States population with this pubic use database, which is available through SEER*Stat software.

United States Cancer Statistics: Restricted Access Data
CDC’s National Center for Health Statistics Research Data Center provides access to two data sets. United States Cancer Statistics Restricted Access Data includes variables that are not in the public use database, such as county at diagnosis, site-specific factors, and prognostic measures. National Program of Cancer Registries Comparative Effectiveness Research Data includes data items on patient characteristics and unique detailed treatment and biomarker data for breast, colon, and rectal cancers, as well as chronic myeloid leukemia cases diagnosed in 2011.